Fields »
ABOUT
HELP
BLOG

186 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
SLC31A1Solute carrier family 31 (copper transporter), member 1
Renal cancer: 2.20e-6
Thyroid cancer: 2.03e-4
Expressed in all
TRMT10ATRNA methyltransferase 10A
Nucleoplasm
Nucleoli
Actin filaments
Cytosol		Thyroid cancer: 2.14e-4
Expressed in all
INTS2Integrator complex subunit 2
NucleoplasmThyroid cancer: 2.20e-4
Liver cancer: 4.37e-4
Mixed
RNF14Ring finger protein 14
CytosolRenal cancer: 1.71e-4
Thyroid cancer: 2.21e-4
Expressed in all
SLC25A51Solute carrier family 25, member 51N/A
MitochondriaLiver cancer: 5.67e-5
Renal cancer: 1.52e-4
Thyroid cancer: 2.21e-4
Expressed in all
MAZMYC-associated zinc finger protein (purine-binding transcription factor)
NucleusThyroid cancer: 2.22e-4
Renal cancer: 5.15e-4
Expressed in all
PAICSPhosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
CytosolRenal cancer: 5.85e-5
Liver cancer: 1.50e-4
Thyroid cancer: 2.41e-4
Ovarian cancer: 8.44e-4
Expressed in all
BCL2B-cell CLL/lymphoma 2
Nucleoplasm
Nuclear membrane		Renal cancer: 1.29e-8
Cervical cancer: 5.13e-5
Thyroid cancer: 2.47e-4
Tissue enhancedthyroid gland:69.2
SLC25A46Solute carrier family 25, member 46
MitochondriaThyroid cancer: 2.52e-4
Colorectal cancer: 8.41e-4
Expressed in all
METTL10Methyltransferase like 10
Nucleoplasm
Nuclear bodies		Thyroid cancer: 2.53e-4
Prostate cancer: 4.82e-4
Mixed
C11orf63Chromosome 11 open reading frame 63
Nucleoplasm
Golgi apparatus		Endometrial cancer: 7.94e-5
Thyroid cancer: 2.58e-4
Renal cancer: 8.77e-4
Tissue enhancedtestis:63.4
ARFGAP3ADP-ribosylation factor GTPase activating protein 3
Golgi apparatus
Cytosol		Endometrial cancer: 8.97e-6
Thyroid cancer: 2.65e-4
Expressed in all
ADM2Adrenomedullin 2
Thyroid cancer: 2.72e-4
Tissue enhancedthyroid gland:19.2
SAE1SUMO1 activating enzyme subunit 1
Liver cancer: 5.49e-8
Renal cancer: 8.15e-5
Thyroid cancer: 2.76e-4
Expressed in all
PHTF2Putative homeodomain transcription factor 2
Nucleoplasm
Cytosol		Renal cancer: 3.09e-7
Thyroid cancer: 2.78e-4
Mixed
FADS1Fatty acid desaturase 1
Renal cancer: 1.95e-9
Urothelial cancer: 1.33e-4
Thyroid cancer: 2.79e-4
Expressed in all
CDC14BCell division cycle 14B
Nuclear membraneRenal cancer: 2.97e-10
Thyroid cancer: 2.82e-4
Mixed
PRKD1Protein kinase D1
Plasma membrane
Cytosol		Renal cancer: 2.44e-5
Thyroid cancer: 2.91e-4
Tissue enhancedparathyroid gland:49.5
TRIM45Tripartite motif containing 45
N/A
Cytokinetic bridge
Cytosol		Breast cancer: 1.58e-4
Thyroid cancer: 2.92e-4
Mixed
TFRCTransferrin receptor
Endosomes
Lysosomes		Liver cancer: 1.15e-4
Thyroid cancer: 2.96e-4
Cervical cancer: 3.67e-4
Expressed in all
RPP14Ribonuclease P/MRP 14kDa subunitN/A
Nucleoplasm
Cytosol		Renal cancer: 3.07e-10
Thyroid cancer: 2.96e-4
Expressed in all
LARSLeucyl-tRNA synthetase
Nuclear bodies
Cytosol		Liver cancer: 3.78e-5
Thyroid cancer: 2.98e-4
Expressed in all
CSPP1Centrosome and spindle pole associated protein 1
Microtubule organizing centerThyroid cancer: 2.98e-4
Expressed in all
GCFC2GC-rich sequence DNA-binding factor 2
Nucleoplasm
Cytosol		Thyroid cancer: 3.09e-4
Endometrial cancer: 9.59e-4
Expressed in all
WFS1Wolfram syndrome 1 (wolframin)
Endometrial cancer: 1.13e-6
Thyroid cancer: 3.13e-4
Mixed
TGFBR3Transforming growth factor, beta receptor III
CytosolThyroid cancer: 3.14e-4
Endometrial cancer: 3.36e-4
Head and neck cancer: 4.84e-4
Renal cancer: 4.99e-4
Expressed in all
CANXCalnexin
Endoplasmic reticulumColorectal cancer: 1.38e-4
Thyroid cancer: 3.17e-4
Expressed in all
PHKBPhosphorylase kinase, beta
Golgi apparatusRenal cancer: 3.89e-9
Thyroid cancer: 3.24e-4
Colorectal cancer: 3.69e-4
Expressed in all
MAGED1Melanoma antigen family D1
CytosolThyroid cancer: 3.25e-4
Expressed in all
FBXL17F-box and leucine-rich repeat protein 17
NucleusRenal cancer: 4.60e-8
Thyroid cancer: 3.27e-4
Expressed in all
RAB3IL1RAB3A interacting protein (rabin3)-like 1
CytosolLiver cancer: 1.61e-7
Renal cancer: 1.49e-4
Thyroid cancer: 3.30e-4
Colorectal cancer: 6.08e-4
Mixed
TROVE2TROVE domain family, member 2
Nucleoplasm
Cytosol		Thyroid cancer: 3.31e-4
Expressed in all
KDM6BLysine (K)-specific demethylase 6B
Nuclear specklesThyroid cancer: 3.37e-4
Renal cancer: 6.07e-4
Expressed in all
ITPR1Inositol 1,4,5-trisphosphate receptor, type 1
VesiclesThyroid cancer: 3.43e-4
Tissue enhancedparathyroid gland:104.9
GFPT2Glutamine-fructose-6-phosphate transaminase 2
VesiclesRenal cancer: 2.58e-14
Lung cancer: 2.95e-4
Thyroid cancer: 3.47e-4
Cervical cancer: 9.09e-4
Tissue enhancedadipose tissue:89.7
FAM220AFamily with sequence similarity 220, member A
VesiclesLiver cancer: 5.17e-6
Thyroid cancer: 3.47e-4
Expressed in all
ZMAT4Zinc finger, matrin-type 4
Nucleus
Nucleoli		Thyroid cancer: 3.51e-4
Group enriched8cerebral cortex:10.1
thyroid gland:27.5
PRCCPapillary renal cell carcinoma (translocation-associated)
Nuclear specklesRenal cancer: 8.99e-15
Thyroid cancer: 3.72e-4
Endometrial cancer: 5.55e-4
Liver cancer: 8.63e-4
Expressed in all
BNIP3LBCL2/adenovirus E1B 19kDa interacting protein 3-like
Nuclear speckles
Mitochondria		Renal cancer: 5.92e-5
Thyroid cancer: 3.95e-4
Expressed in all
TBC1D9BTBC1 domain family, member 9B (with GRAM domain)
Nucleus
Nucleoli fibrillar center
Plasma membrane		Thyroid cancer: 3.99e-4
Expressed in all
TBC1D19TBC1 domain family, member 19
Nucleoplasm
Nuclear membrane		Renal cancer: 1.21e-7
Thyroid cancer: 4.06e-4
Mixed
APODApolipoprotein D
Thyroid cancer: 4.12e-4
Breast cancer: 5.51e-4
Stomach cancer: 6.02e-4
Tissue enriched7breast:4546.8
TRIM41Tripartite motif containing 41
Nucleoli
Nuclear bodies		Thyroid cancer: 4.22e-4
Expressed in all
ASPHAspartate beta-hydroxylase
Endoplasmic reticulumRenal cancer: 1.57e-5
Cervical cancer: 8.07e-5
Pancreatic cancer: 1.75e-4
Lung cancer: 3.61e-4
Thyroid cancer: 4.24e-4
Expressed in all
FCGBPFc fragment of IgG binding protein
Golgi apparatus
Plasma membrane
Cytokinetic bridge		Ovarian cancer: 9.70e-6
Head and neck cancer: 1.28e-5
Liver cancer: 4.74e-5
Thyroid cancer: 4.27e-4
Tissue enhancedcolon:194.4
GEMGTP binding protein overexpressed in skeletal muscle
Renal cancer: 1.56e-5
Thyroid cancer: 4.29e-4
Tissue enhancedgallbladder:366.0
VAV2Vav 2 guanine nucleotide exchange factor
VesiclesRenal cancer: 7.39e-7
Thyroid cancer: 4.33e-4
Mixed
SPATA2Spermatogenesis associated 2
Nucleus
Nucleoli fibrillar center		Endometrial cancer: 1.87e-4
Thyroid cancer: 4.53e-4
Melanoma: 9.08e-4
Expressed in all
GDAP1Ganglioside induced differentiation associated protein 1
Mitochondria
Cytosol		Endometrial cancer: 1.82e-4
Lung cancer: 2.68e-4
Thyroid cancer: 4.54e-4
Tissue enhancedcerebral cortex:77.0
EXT1Exostosin glycosyltransferase 1
Lung cancer: 1.20e-5
Thyroid cancer: 4.64e-4
Cervical cancer: 7.04e-4
Expressed in all

« prev | Page of 4 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.